RxDoctor Payments DataLook up a doctor →

Ronald Mayfield

Endocrinology, Diabetes & Metabolism · Spartanburg, SCNPI 1134199755

Payments from drug & device makers

$8,938,989in general payments, 2019–2025

Across 464 payments — averaging $19,265 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$6.6M
  • Novartis$549K
  • Amgen$522K
  • Sanofi US Services Inc.$375K
  • Bayer$213K
  • Regeneron$206K
  • plus $492K from 13 others
$132,416in research payments, 2019–2025

Across 23 payments — averaging $5757.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$108K
  • Novo Nordisk AS$25K

What the payments were for

  • Consulting fees$1,16385%
  • Food & beverage$1108%
  • Education$977%

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,938,989 in reported general payments places this provider in the 95th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.

See all endocrinology, diabetes & metabolism providers in South Carolina

Other endocrinology, diabetes & metabolism in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →